Menendez’s Opposition to Drug Pricing Reform May Imperil Democratic Agenda

Sen. Bob Menendez, D-N.J., has not budged from his earlier criticism of a popular bill to lower the costs of prescription drugs, creating another possible hurdle for Democrats as they finalize a reconciliation package to achieve President Joe Biden’s Build Back Better agenda. After raising concerns over the summer that the pharmaceutical industry would get unfairly “taxed,” Menendez confirmed to The Intercept on September 29 that he’s not in favor of the Lower Drug Costs Now Act, or H.R. 3.

Read the source article at theintercept.com
2021-10-05 23:21:00